2D Structure
loading...
2D chemical structural formula diagram.
3D Structure
loading...
This 3D model represents a theoretically simulated conformation and is for reference only.
Check the
Ulixertinib (BVD-523)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)-4-pyridinyl]-1H-pyrrole-2-carboxamide | |
|---|---|---|
| CAS Number | 869886-67-9 | |
| Molecular Formula |
C21H22Cl2N4O2 |
|
| Molecular Weight (MW) | 433.33 | |
| SMILES | CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl | |
| InChIKey | KSERXGMCDHOLSS-LJQANCHMSA-N |
|
Concentration
Volume
Mass
|
1 mg | 5 mg | 10 mg |
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
86 mg/mL
(198.46 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 86 mg/mL |
| Water | Insoluble |
| DMSO |
86 mg/mL
(198.46 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 15 mg/mL |
| Water | Insoluble |
| DMSO |
86 mg/mL
(198.46 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 43 mg/mL |
| Water | Insoluble |
| DMSO |
86 mg/mL
(198.46 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 43 mg/mL |
| Water | Insoluble |
| DMSO |
87 mg/mL
(200.77 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 22 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Ulixertinib (BVD-523) Mechanism of Action: ERK1/2 Inhibition in Melanoma Cell Research
- Ulixertinib (BVD-523) Clinical Trials
- Ulixertinib (BVD-523) Working Concentration | Cell Culture | Treatment
- Ulixertinib (BVD-523) Solubility in DMSO
- Ulixertinib (BVD-523) Stock Solution
- Ulixertinib (BVD-523) Storage
- Ulixertinib (BVD-523) Stability
- Ulixertinib (BVD-523) Combination Database
- Ulixertinib (BVD-523) Molecular Weight
- Ulixertinib (BVD-523) SMILES
- Ulixertinib (BVD-523) CAS Number
- Ulixertinib (BVD-523) IC50 for Cell-based and Cell-free Assays
- Ulixertinib (BVD-523) Sigma (AMBH2D6FB286)? Try a better option.
- Ulixertinib (BVD-523) MedChemExpress (HY-15816)? Try a better option.
- Ulixertinib (BVD-523) Cayman (18298)? Try a better option.
- Ulixertinib (BVD-523) APExBIO (B1106)? Try a better option.
- Ulixertinib (BVD-523) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.